Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys.

Journal of Lipid Research
Mathieu R BrodeurJean-Claude Tardif

Abstract

Inhibition of cholesteryl ester transfer protein (CETP) increases HDL cholesterol (HDL-C) levels. However, the circulating CETP level varies and the impact of its inhibition in species with high CETP levels on HDL structure and function remains poorly characterized. This study investigated the effects of dalcetrapib and anacetrapib, the two CETP inhibitors (CETPis) currently being tested in large clinical outcome trials, on HDL particle subclass distribution and cholesterol efflux capacity of serum in rabbits and monkeys. New Zealand White rabbits and vervet monkeys received dalcetrapib and anacetrapib. In rabbits, CETPis increased HDL-C, raised small and large α-migrating HDL, and increased ABCA1-induced cholesterol efflux. In vervet monkeys, although anacetrapib produced similar results, dalcetrapib caused opposite effects because the LDL-C level was increased by 42% and HDL-C decreased by 48% (P < 0.01). The levels of α- and preβ-HDL were reduced by 16% (P < 0.001) and 69% (P < 0.01), resulting in a decrease of the serum cholesterol efflux capacity. CETPis modulate the plasma levels of mature and small HDL in vivo and consequently the cholesterol efflux capacity. The opposite effects of dalcetrapib in different species indic...Continue Reading

References

Jan 1, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·R McPhersonA R Tall
Aug 22, 1997·The Journal of Biological Chemistry·Y JiA R Tall
Sep 9, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·C W RittershausU S Ryan
Apr 18, 2003·Journal of Lipid Research·Ashley M Vaughan, John F Oram
Nov 1, 2003·The International Journal of Biochemistry & Cell Biology·David Rhainds, Louise Brissette
Nov 1, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Kerry-Anne Rye, Philip J Barter
Dec 6, 2005·Journal of Lipid Research·Francesca ZimettiGeorge H Rothblat
Dec 22, 2006·Journal of Lipid Research·Bela F AsztalosLaura Calabresi
Nov 7, 2007·The New England Journal of Medicine·Philip J BarterUNKNOWN ILLUMINATE Investigators
Jun 3, 2009·Nature Reviews. Cardiology·Danielle Duffy, Daniel J Rader
Jan 14, 2011·The New England Journal of Medicine·Amit V KheraDaniel J Rader
Feb 26, 2011·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Olaf Kuhlmann, Katja Heinig
Jul 16, 2011·The American Journal of Cardiology·Lin T GueyMary J Malloy
May 1, 2012·Journal of Pharmaceutical and Biomedical Analysis·Katja HeinigTomoko Yamashita
Nov 7, 2012·The New England Journal of Medicine·Gregory G SchwartzUNKNOWN dal-OUTCOMES Investigators
Jul 23, 2013·Biochimica Et Biophysica Acta·Cyrille MaugeaisEric J Niesor
Dec 3, 2013·Journal of Lipid Research·Richard E Morton, Lahoucine Izem
Jun 24, 2014·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Hiroaki TakuboMotohiro Kogayu
Jul 12, 2014·The New England Journal of Medicine·Martin J LandrayJane Armitage
Jan 15, 2015·Circulation. Cardiovascular Genetics·Jean-Claude TardifMarie-Pierre Dubé
Jan 27, 2015·The Journal of Pharmacology and Experimental Therapeutics·Francisco J RiosRhian M Touyz
Jul 16, 2016·Circulation. Cardiovascular Genetics·Jean-Claude TardifMarie-Pierre Dubé

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
ELISA
size-exclusion chromatography

Clinical Trials Mentioned

NCT01252953
NCT02525939

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.